IL231048A0 - Inhibitors of leukotriene-mediated activity for treating statin therapy side effects - Google Patents

Inhibitors of leukotriene-mediated activity for treating statin therapy side effects

Info

Publication number
IL231048A0
IL231048A0 IL231048A IL23104814A IL231048A0 IL 231048 A0 IL231048 A0 IL 231048A0 IL 231048 A IL231048 A IL 231048A IL 23104814 A IL23104814 A IL 23104814A IL 231048 A0 IL231048 A0 IL 231048A0
Authority
IL
Israel
Prior art keywords
leukotriene
inhibitors
side effects
statin therapy
mediated activity
Prior art date
Application number
IL231048A
Other languages
Hebrew (he)
Original Assignee
Yeda Res & Dev
Rubinstein Menachem
Dvash Riesenfeld Efrat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Rubinstein Menachem, Dvash Riesenfeld Efrat filed Critical Yeda Res & Dev
Priority to IL231048A priority Critical patent/IL231048A0/en
Publication of IL231048A0 publication Critical patent/IL231048A0/en
Priority to CN201580020281.XA priority patent/CN106456999A/en
Priority to JP2016552577A priority patent/JP2017510558A/en
Priority to EP15751737.6A priority patent/EP3107626A4/en
Priority to PCT/IL2015/050184 priority patent/WO2015125138A1/en
Priority to PCT/IL2015/050183 priority patent/WO2015125137A1/en
Priority to US15/118,196 priority patent/US20170172979A1/en
Priority to IL247334A priority patent/IL247334A0/en
Priority to US15/798,530 priority patent/US20180064682A1/en

Links

IL231048A 2014-02-19 2014-02-19 Inhibitors of leukotriene-mediated activity for treating statin therapy side effects IL231048A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL231048A IL231048A0 (en) 2014-02-19 2014-02-19 Inhibitors of leukotriene-mediated activity for treating statin therapy side effects
CN201580020281.XA CN106456999A (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
JP2016552577A JP2017510558A (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity to treat the side effects of statin therapy
EP15751737.6A EP3107626A4 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
PCT/IL2015/050184 WO2015125138A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
PCT/IL2015/050183 WO2015125137A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene mediated activity for alleviating chemotherapy side effects and stress induced cell death
US15/118,196 US20170172979A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
IL247334A IL247334A0 (en) 2014-02-19 2016-08-17 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
US15/798,530 US20180064682A1 (en) 2014-02-19 2017-10-31 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL231048A IL231048A0 (en) 2014-02-19 2014-02-19 Inhibitors of leukotriene-mediated activity for treating statin therapy side effects

Publications (1)

Publication Number Publication Date
IL231048A0 true IL231048A0 (en) 2014-05-28

Family

ID=51221130

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231048A IL231048A0 (en) 2014-02-19 2014-02-19 Inhibitors of leukotriene-mediated activity for treating statin therapy side effects

Country Status (1)

Country Link
IL (1) IL231048A0 (en)

Similar Documents

Publication Publication Date Title
IL285201A (en) Ezh2 inhibitors for treating lymphoma
IL247334A0 (en) Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
ZA201700183B (en) Acetylcholinesterase inhibitors for treatment of dermatological conditions
IL264048A (en) Pde9 inhibitors for treatment of peripheral diseases
SG10201801562PA (en) Combination method for treatment of cancer
IL257061A (en) Inhibitors of ezh2
PT3233071T (en) Method of treating or preventing ras-mediated diseases
PL3164394T3 (en) Gls1 inhibitors for treating diseases
EP3152195A4 (en) Mth1 inhibitors for treatment of cancer
HK1256174A1 (en) Vap-1 inhibitors for treating pain
IL274198A (en) Use of nox inhibitors for treatment of cancer
PL3364971T3 (en) Heterocyclic pdk1 inhibitors for use to treat cancer
IL231048A0 (en) Inhibitors of leukotriene-mediated activity for treating statin therapy side effects
IL244620A0 (en) Laquinimod combination therapy for treatment of multiple sclerosis
IL247109A0 (en) Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy
GB201521547D0 (en) New therapeutic uses of enzyme inhibitors
GB201521541D0 (en) New therapeutic uses of enzyme inhibitors
PT3851537T (en) Treatment of hyperbilirubinemia
GB201421812D0 (en) New therapeutic uses of enzyme inhibitors
GB201410529D0 (en) New therapeutic uses of enzyme inhibitors
GB201418640D0 (en) Agents and methods for treatment of cancer